60 DEGREES PHARMACEUTICALS, INC. Operating Lease Right-of-Use Assets
60 DEGREES PHARMACEUTICALS, INC. (SXTP) had Operating Lease Right-of-Use Assets of $13.52 thousand as of 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-03-27
- 2023-12-31: Operating Lease, Right-of-Use Asset $13.52K.
- 2023-09-30: Operating Lease, Right-of-Use Asset $26.53K.
- 2023-06-30: Operating Lease, Right-of-Use Asset $39.07K.
- 2022-12-31: Operating Lease, Right-of-Use Asset $12.65K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-12-31 | $13.52K 10-K · filed 2025-03-27 |
| 2023-09-30 | $26.53K 10-Q · filed 2023-11-20 |
| 2023-06-30 | $39.07K 10-Q · filed 2023-08-25 |
| 2022-12-31 | $12.65K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |